Georgia Tech chemists are exploring the behavior of a complex protein associated with glaucoma — characterizing one of the largest amyloid-forming proteins to date.

CMDI merges disciplines, aggressively recruiting microbiologist ‘superstars’ to take back the high ground from antibiotic-resistant pathogens and emerging diseases — and to harness microbes for new medicines, cleaner environments, and climate solutions.

Georgia Tech researchers have engineered one of the world’s first yeast cells able to harness energy from light, expanding our understanding of the evolution of this trait — and paving the way for advancements in biofuel production and cellular aging.

BME researcher's immunometabolism approach pioneers single cell spatial metabolomics

Georgia Tech researcher plans to probe subcellular and cellular organization, counting molecular neighborhoods and building to better understand the spatial organization of cells.

A newly funded research project might one day lead to the development of a pill or capsule able to boost the effectiveness of traditional vaccines against influenza

Philip Santangelo wants to build a toolbox of mRNA drugs to activate or shut off specific genes to help the immune system fight cancer and other disorders.

DASI Simulations, uses AI and computer vision in its technology for personalized and more accurate heart valve replacement modeling.

As we kick off a new year, hear from six young, pioneering Georgia Tech researchers who are tackling some of the world’s most complicated issues and working on solutions.

Jackson Medical's GloShield device finds success in American hospitals